Development of a biomarker scoring system for use in graft-versus-host disease
- PMID: 27416114
- PMCID: PMC5493962
- DOI: 10.2217/bmm-2016-0162
Development of a biomarker scoring system for use in graft-versus-host disease
Keywords: Ann Arbor score; algorithm; biomarkers; graft-versus-host disease (GVHD); treatment.
Conflict of interest statement
JL Ferrara and JE Levine have pending patents on biomarkers for diagnosis of graft-versus-host disease. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Similar articles
-
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.Lancet Haematol. 2015 Jan;2(1):e21-9. doi: 10.1016/S2352-3026(14)00035-0. Epub 2014 Dec 23. Lancet Haematol. 2015. PMID: 26687425 Free PMC article. Clinical Trial.
-
Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.Ann Hematol. 2017 Jul;96(7):1127-1133. doi: 10.1007/s00277-017-2999-5. Epub 2017 Apr 26. Ann Hematol. 2017. PMID: 28447161
-
Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.Expert Rev Proteomics. 2017 Nov;14(11):997-1006. doi: 10.1080/14789450.2017.1388166. Epub 2017 Oct 12. Expert Rev Proteomics. 2017. PMID: 28974115 Review.
-
Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.Blood Cells Mol Dis. 2019 Feb;74:5-12. doi: 10.1016/j.bcmd.2018.10.001. Epub 2018 Oct 4. Blood Cells Mol Dis. 2019. PMID: 30344086
-
[Significance of ST2 in the Early Diagnosis and Treatment of Graft-Versus-Host Disease--Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):307-10. doi: 10.7534/j.issn.1009-2137.2016.01.060. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913443 Review. Chinese.
Cited by
-
Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.Biol Blood Marrow Transplant. 2020 Jun;26(6):1050-1070. doi: 10.1016/j.bbmt.2020.01.020. Epub 2020 Feb 18. Biol Blood Marrow Transplant. 2020. PMID: 32081787 Free PMC article. Clinical Trial.
-
Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.Biol Blood Marrow Transplant. 2017 Aug;23(8):1257-1263. doi: 10.1016/j.bbmt.2017.04.029. Epub 2017 May 3. Biol Blood Marrow Transplant. 2017. PMID: 28478120 Free PMC article.
-
Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD.Int J Hematol. 2019 Apr;109(4):451-462. doi: 10.1007/s12185-019-02605-1. Epub 2019 Feb 6. Int J Hematol. 2019. PMID: 30725359 Clinical Trial.
References
-
- Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br. J. Haematol. 1997;97(4):855–864. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources